Aligos Therapeutics Stock Price History

ALGS Stock  USD 11.52  0.23  1.96%   
If you're considering investing in Aligos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aligos Therapeutics stands at 11.52, as last reported on the 20th of March, with the highest price reaching 12.19 and the lowest price hitting 11.28 during the day. Aligos Therapeutics secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23 % return per unit of risk over the last 3 months. Aligos Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aligos Therapeutics' Mean Deviation of 5.47, standard deviation of 7.4, and Risk Adjusted Performance of (0.20) to double-check the risk estimate we provide.
  
Aligos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2345

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsALGS

Estimated Market Risk

 7.4
  actual daily
66
66% of assets are less volatile

Expected Return

 -1.74
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Aligos Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aligos Therapeutics by adding Aligos Therapeutics to a well-diversified portfolio.

Aligos Therapeutics Stock Price History Chart

There are several ways to analyze Aligos Stock price data. The simplest method is using a basic Aligos candlestick price chart, which shows Aligos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 6, 202545.62
Lowest PriceMarch 13, 202510.28

Aligos Therapeutics March 20, 2025 Stock Price Synopsis

Various analyses of Aligos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aligos Stock. It can be used to describe the percentage change in the price of Aligos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aligos Stock.
Aligos Therapeutics Price Daily Balance Of Power(0.25)
Aligos Therapeutics Accumulation Distribution 4,762 
Aligos Therapeutics Price Action Indicator(0.33)
Aligos Therapeutics Price Rate Of Daily Change 0.98 

Aligos Therapeutics March 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Aligos Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Aligos Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Aligos Stock and then apply it to test your longer-term investment strategies against Aligos.

Aligos Stock Price History Data

OpenHighLowCloseVolume
03/20/2025 11.45  12.19  11.28  11.52  63,788 
03/19/2025 10.88  11.90  10.81  11.75  128,380 
03/18/2025 11.04  11.44  10.68  10.76  108,716 
03/17/2025 11.49  12.12  11.39  11.67  97,957 
03/14/2025 10.75  11.76  10.62  11.44  137,755 
03/13/2025 10.85  10.85  9.70  10.28  138,861 
03/12/2025 10.98  11.17  10.19  10.81  171,870 
03/11/2025 10.30  10.80  9.67  10.51  153,465 
03/10/2025 12.16  12.49  9.51  10.41  348,020 
03/07/2025 13.21  13.41  11.91  12.94  260,306 
03/06/2025 14.20  14.43  13.39  13.48  119,469 
03/05/2025 14.11  14.52  13.71  14.40  117,189 
03/04/2025 13.54  14.60  12.76  14.34  251,088 
03/03/2025 17.18  17.25  14.17  14.50  207,176 
02/28/2025 16.08  17.39  15.88  16.87  134,108 
02/27/2025 18.21  18.61  16.60  16.76  184,191 
02/26/2025 17.63  18.75  17.39  17.75  268,683 
02/25/2025 17.70  17.89  16.02  17.33  276,284 
02/24/2025 18.76  18.99  17.17  17.82  292,361 
02/21/2025 21.47  21.88  18.13  18.63  339,064 
02/20/2025 22.26  22.40  20.51  20.85  140,675 
02/19/2025 22.38  23.13  21.61  22.27  114,530 
02/18/2025 24.11  24.33  22.48  22.79  130,646 
02/14/2025 21.13  23.73  20.54  23.67  304,898 
02/13/2025 21.02  21.95  20.12  21.01  262,037 
02/12/2025 25.54  26.38  20.16  21.01  722,375 
02/11/2025 27.00  27.30  25.54  26.02  150,512 
02/10/2025 28.18  29.54  27.44  27.70  192,188 
02/07/2025 27.64  28.91  26.61  27.53  247,484 
02/06/2025 25.52  28.10  25.02  27.50  261,476 
02/05/2025 26.00  26.70  24.70  25.32  226,167 
02/04/2025 23.01  26.15  22.90  26.03  206,859 
02/03/2025 23.40  25.24  22.56  22.57  201,348 
01/31/2025 24.35  27.61  24.10  25.80  375,065 
01/30/2025 24.20  24.99  23.24  23.74  267,162 
01/29/2025 24.83  26.40  23.95  23.95  161,757 
01/28/2025 26.01  26.84  21.65  24.76  595,135 
01/27/2025 29.41  30.02  25.45  25.67  308,524 
01/24/2025 32.27  33.04  30.22  30.43  148,900 
01/23/2025 32.65  33.45  31.08  32.00  183,102 
01/22/2025 34.14  34.37  32.00  32.86  174,603 
01/21/2025 34.28  34.28  32.50  33.79  158,747 
01/17/2025 32.89  34.34  31.50  34.24  222,939 
01/16/2025 32.01  32.43  30.31  31.61  194,322 
01/15/2025 30.84  33.44  30.84  31.73  263,272 
01/14/2025 35.04  35.30  29.35  30.05  346,942 
01/13/2025 32.08  35.00  31.00  34.34  319,356 
01/10/2025 36.09  37.12  28.10  33.71  670,094 
01/08/2025 40.13  40.81  36.36  38.39  373,695 
01/07/2025 46.25  46.32  40.56  40.92  509,969 
01/06/2025 44.50  46.80  42.50  45.62  555,736 
01/03/2025 40.35  44.30  40.30  43.42  377,187 
01/02/2025 40.45  42.25  38.00  39.82  457,700 
12/31/2024 41.15  41.30  34.53  39.84  617,482 
12/30/2024 39.88  41.14  37.06  40.47  352,573 
12/27/2024 43.00  44.39  39.54  41.15  464,971 
12/26/2024 40.00  43.94  38.13  43.37  787,957 
12/24/2024 40.98  42.42  38.90  39.34  290,741 
12/23/2024 42.10  42.95  38.61  38.85  407,161 
12/20/2024 36.78  41.64  36.35  39.84  469,153 
12/19/2024 35.00  39.30  34.60  38.35  449,674 

About Aligos Therapeutics Stock history

Aligos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aligos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aligos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aligos Therapeutics stock prices may prove useful in developing a viable investing in Aligos Therapeutics
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. The company was incorporated in 2018 and is headquartered in South San Francisco, California. Aligos Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.

Aligos Therapeutics Stock Technical Analysis

Aligos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aligos Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aligos Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Aligos Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aligos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aligos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aligos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Aligos Stock Analysis

When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.